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Type 2 diabetes mellitus (T2DM) is a global epidemic that contributes to a significant burden of disease worldwide [1] . The rapid increase in T2DM prevalence over the past few decades [2] has led to the projection of 592 million patients by 2035 [1] . Improvements in metabolic control, mediated by healthy lifestyle behaviors including physical and healthy diet activity, play an important role in managing T2DM by preventing and delaying disease progression of cardiovascular complications.
Besides conventional approaches such as pharmaceutical interventions and optimal medication, self-management education is an empowering process that teaches patients to initiate behavioral changes and strengthen management of their disease [3, 4] . With respect to diabetes, self-management education refers to "the ongoing process of facilitating the knowledge, skills, and ability necessary for diabetes self-care". [5] Despite considerable variations in the organization of structured diabetes self-management education, systematic reviews [6] [7] [8] and meta-analyses [9] [10] [11] have demonstrated improvements in glycemic and cardiovascular risk factor control in both individual and group-based patient education interventions.
Significant reduction in diabetes-related complications as a result of diabetes education in secondary care setting was found. In a systematic review of randomized controlled trials on educational interventions for T2DM [6] , studies focused on the effect of diabetes education on metabolic control and intake of oral hypoglycaemic treatment. To date, only one study [12] investigated the effect of diabetes education on long-term cardiovascular disease outcomes.
Thus, the study (structured intensive diabetes education programme, SIDEP) [12] on a sample of 547 Korean patients with T2DM under secondary care, reported that patients with intensive diabetes education programme, at a follow-up of beyond four years, had lower frequency of hospital admissions related to diabetic complications than those who did not take part in the programme. However, whether or not diabetes education in primary care settings has had a significant impact on reducing incidence of cardiovascular disease outcomes and mortality remains uncertain. There is paucity of large population-based studies on the long-term cardiovascular benefits associated with diabetes education programme in a primary care setting. A recent study [13] on the impact of a Patient Empowerment Programme (PEP) intervention on metabolic control provides evidence supporting the value of structured diabetes education for T2DM patients in primary care settings. Given the significant improvements in metabolic control associated with PEP, we evaluated whether those benefits would translate into a reduction in cardiovascular disease events.
This population-based propensity matched cohort study was carried out to evaluate the influence of implementing PEP in a primary care versus the usual clinical practice. The risks of incidence of cardiovascular disease and all-cause mortality events between the PEP and usual clinical practice were compared. It was hypothesized that PEP participants would have significantly lower risks of cardiovascular disease and all-cause mortality events.
Methods
PEP was launched in 2010 as a tertiary-wide primary care service component across the Hong Kong Hospital Authority with the purpose of providing quality chronic disease management to enhance primary care services. In the first evaluation cycle, from 1 March, 2010 to 30 September, 2010, two non-government organizations (NGOs) who were highly experienced in providing community medical education services, were invited to participate in the programme. From August 2011 onwards, four NGOs were invited to deliver PEP, offering full coverage of services across all district clusters in Hong Kong. A detailed description of the PEP setting, mode of education delivery and results from the first evaluation has been previously published [13] . The main function of PEP is to deliver sessions on disease-specific knowledge, self-management skills, self-efficacy and lifestyle modification to T2DM patients. This analysis summarized the second set of evaluation data derived from the quality of care evaluation of PEP provided by four NGOs with subsidies. patients who had never participated in PEP on or before 30 June, 2013 were matched to PEP subjects on propensity score matching (described below) as non-PEP group.
We defined the subjects as having a history of co-morbidities and diagnosis of CVD Ethics approval of this study was granted by the institutional review board and clinical trial registry (NCT01935349, ClinicalTrials.gov).
Cardiovascular Disease
In this study, five outcome events were of interest: 1) first CVD event with one of the following diagnoses: coronary heart disease (CHD), stroke, or heart failure, 2) CHD, 3) stroke, 4) heart failure, and 5) all-cause mortality. Incidence of CHD was defined as the earliest date of diagnosis with ICD-9-CM of 410. 
Baseline Covariates
Covariates of patients included the collection of socio-demographic, biomedical data, disease characteristics, treatment modalities, and enrolment of co-intervention for diabetes [14, 15] at baseline. Socio-demographic characteristics of patients included sex, age, smoking status, alcohol status, and educational level. Biomedical data included body mass index (BMI), HbA1C level, blood pressure, lipid profile, triglyceride and estimated glomerular filtration rate (eGFR) taken within a six-month period from baseline. Disease characteristics included the duration of T2DM, family history of T2DM and the use of insulin.
Propensity Score Matching
A propensity score is the conditional probability of being selected for the intervention group given the observed covariates [16] . The technique aims to form equivalent PEP intervention and non-PEP comparison groups by summarizing relevant baseline characteristics of each patient into a single-index variable (the propensity score) and then matching patients in the non-PEP comparison pool to patients in the PEP intervention group based on the value of the propensity score [17] [18] [19] . Correspondingly, the propensity score for each patient was generated by logistic regression, modelling the PEP intervention as dependent variable and baseline covariates of patients as independent variables. Variables used for propensity score matching included sex, age, smoking status, alcohol status, educational level, HbA1c level, blood pressure, triglyceride, total cholesterol-to-high density lipoprotein cholesterol ratio, low density lipoprotein cholesterol, eGFR, duration of T2DM (≤5 years/ >5-10 years/ >10 years), history of hypertension, family history of T2DM, use of insulin and enrolment of cointervention. The propensity score mapping was made by using the "psmatch2" command [20] by one-to-one matching with the nearest neighbour and without replacement approach in STATA.
Data Analysis
Descriptive statistics were used to calculate the baseline characteristics of sociodemographic and clinical data in PEP and non-PEP groups after propensity score matching.
Differences in baseline characteristics between PEP and non-PEP groups were tested using independent t-test for continuous variables or Chi-square test for categorical variables. The incidence rate of all-cause mortality and CVD events in PEP and non-PEP groups were reported. The 95% confidence interval (CI) of incidence rate was constructed based on the assumption that the observed incident cases followed a Poisson distribution.
Cox proportional hazards regression was performed to estimate the effect of PEP on the dependent variable of first CVD events. Multivariable cox proportional hazards regression models in propensity score matching were performed, accounting for all baseline characteristics of patients. Sensitivity analysis was performed using the PEP participants who completed the programme and propensity matched non-PEP participants. For each model, survival curves were estimated by Kaplan-Meier method and their differences between PEP and non-PEP groups were compared using the log-rank test. Hazard ratio (HR) and its 95% confidence intervals were reported for each variable in the regression models. Predictive accuracy of Cox models was assessed and compared using Harrell's discrimination C-index, ranging from zero to one. A value of 0.5 indicates no predictive discrimination, and values of 0 or 1.0 indicate perfect separation of patients [21] .
Goodness-of-fit for Cox regression model were assessed using Akaike information criterion (AIC) and Bayesian information criterion (BIC).
All statistical analyses were performed using STATA Version 13.0 (StataCorp LP. College Station, Texas, U.S.). All significance tests were two-tailed and those with a p-value less than 0.05 were considered statistically significant. 
Results

Multivariable cox Regression Model
Multivariable cox regression analyses on the dependent variable of all-cause mortality and cardiovascular disease events are shown in 
Discussion
This is the first study investigating the association of a structured diabetes education Nonetheless, given the paucity of longitudinal data on observed events among subjects with or without diabetes education program, only the association of a diabetes education programme with occurrence of diabetes-related hospitalization has been investigated so far [22] . Recent study showed that subjects enrolling in education programme generally had a significant HR of 0.10 (95%CI: 0.023-0.438; P=0.002) of being hospitalized due to diabetes-related acute events when compared to subjects in control group. The SIDEP [12] , which was based on T2DM patients on secondary care, reported significantly lower diabetes-related hospitalization in those with diabetes education group than those without.
Diabetes-related acute events may be in part attributed to CVD events but those previous studies did not display the breakdown information about the reduction in occurrence of CVD events. Therefore, the increased risk for CVD events for PEP participants compared with non-PEP participants was mainly driven by the occurrence of stroke and heart failure, and less by the occurrence of CHD. There was no evidence of a significant reduction in CHD events among the PEP group compared with the non-PEP group, suggesting that the incidence of stroke and heart failure played an important role in the significant effect of PEP on incidence of composite first CVD events. Consequently, the current study underlined the need for comprehensive outcome evaluation which further breakdown composite CVD outcome into subtypes, rather than examination of single composite CVD outcome.
Structured diabetes education curriculum delivered in the PEP group resulted in a remarkable reduction by 19.3% and 43.6% in the incidence of CVD events and incidence of all-cause mortality, respectively. It is noteworthy that the effect of PEP on the event occurrence was comparable with the effect of international randomized controlled trials focusing on intensive glucose control. Empirical evidence from population-based randomized controlled trials that had intervened with intensified glucose control therapy over a prolonged follow-up period, for instance, UKPDS [23] and Steno-2 [24] trial, were undoubtedly effective in decreased risk of CVD events and all-cause mortality. However, results from ADVANCE trial [25] showed that there was no significant difference in the incidence of all-cause mortality between the intervention and control groups although intervention was significantly associated with decreased risk of CVD events. Moreover, the intensive lifestyle intervention in Look AHEAD trial [26] focusing on overweight or obese T2DM were not associated with any reduction in CVD events, though weight loss was significant, after a median of 10-year period. Therefore, this population-based propensity matched study demonstrated the beneficial effects of PEP in reducing CVD and all-cause mortality events, supporting the public-private partnership and integration of the health sector with NGOs for service delivery in diabetes care.
Strengths and Limitations of this study
The strengths of this study included the use of a population-based cohort of patients with T2DM in Hong Kong Hospital Authority administrative database that was highly representative of the Hong Kong general population. Since the clinical characteristics were well captured by the administrative database through routine clinical practice, this allowed for the consideration of important baseline covariates such as physical assessment, laboratory results, diabetes-related medical history, and drugs dispensed for propensity score matching. Given the control of baseline covariates achieving balance in the PEP and non-PEP groups, propensity score matching was applied to offset the selection bias in this sample.
There were several limitations in this study. First, the current study was not a randomized controlled trial so it could not eliminate bias in the PEP group on outcomes. The clinical data coming from the 'real-world' setting were extracted from routinely collected medical records in an administrative database that was not specially designed for this cohort study.
Both the PEP and non-PEP participants with available baseline covariates were presumably included in the analysis. Therefore, the unobserved baseline covariates were not taken into account for analysis. Many subjects in the PEP group had also participated in a concurrent multi-disciplinary risk assessment and management program [14, 15] that might have added benefit to CVD outcomes. To confirm the benefit of PEP, a multi-center cluster randomized controlled trial, the strongest study design implemented in DESMOND [27] , would be required. However, it may not be possible to conduct such a high-evidence trial in the 'real-world' primary care setting. Second, the long-term benefits of PEP on outcomes still remains uncertain after the second year. A longer follow-up period of beyond 21.5 months on the sustained benefits of outcomes in the intervention group compared to control group will be studied. Third, not all PEP participants were included in the analysis due to missing values. Therefore the propensity score could not be calculated. However, about 80% of eligible PEP participants were included in the analysis.
Finally, data from this study was not entirely representative of Chinese populations in other parts of the world, or those under secondary care or in the private sector. However, findings were generated from a large population-based database of the public service that manage over 50% of diabetic patients in Hong Kong.
Conclusion
In conclusion, the findings of this study showed that enrolment in the Patient Empowerment Programme (PEP) was associated with decreased all-cause mortality and CVD events, especially with stroke and heart failure, in patients with T2DM. Programme completion was related to the reductions in CVD events. Results of this study provided evidence that a structured diabetes education programme led to at least a short-term reduction of CVD and deaths from any cause, in addition to the benefits on metabolic control and quality of primary care among T2DM patients . Future studies about the longterm benefits of PEP on mortality and CVD outcomes are warranted.
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